ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 660

Strain-Dependent IL-17A Secretion By CD4-CD8- DN αβ T Cells Correlates with Disease Susceptibility in Murine Spondyloarthritis

Imtiyaz Hossain, Mederbek Matmusaev and Joerg Ermann, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: IL-23, lymphocytes, mouse model and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hydrodynamic injection of IL-23 minicircles into adult B10.RIII mice induces an inflammatory disease with phenotypic features of human spondyloarthritis. Tissue-resident CD4-CD8- double negative (DN) T cells secreting IL-17A in response to stimulation with IL-23 are thought to be critical in this model. To further dissect disease pathogenesis, IL-23 minicircle injection into genetically modified mice would be informative. C57BL/6, the background strain for most genetically engineered mice, has been shown to be less permissive than B10.RIII in several autoimmune or inflammatory disease models. Here, we tested the susceptibility of C57BL/6 mice to IL-23 minicircle-induced spondyloarthritis and compared number and function of DN T cells between C57BL/6 and B10.RIII mice.

Methods: Adult C57BL/6 and B10.RIII mice were injected with IL-23 minicircles and monitored clinically for disease development. IL-23 induction was measured by quantitative PCR (liver tissue) and ELISA (serum). Single cells suspensions were prepared from blood, liver, spleen, skin and the Achilles tendon enthesis. Cells were analyzed by multicolor flow cytometry. IL-17A production was measured by intracellular staining after stimulation with IL-23/IL-1β or PMA/Ionomycin in the presence of Golgi-Stop for 4 hours.

Results: In contrast to B10.RIII mice, C57BL/6 mice were resistant to induction of IL-23 minicircle-induced spondyloarthritis. While IL-23 expression did not differ between the two strains, C57BL/6 mice failed to develop paw swelling or psoriasis-like skin changes over the observation period of up to 4 weeks. Frequency and number of DN αβ and γδ T cells were not different in the five tissues analyzed. However, upon in vitro stimulation, we observed a statistically significantly higher frequency of IL-17A positive DN αβ T cells in susceptible B10.RIII mice compared with resistant C57BL/6 animals.

Conclusion: C57BL/6 mice in our animal facility are resistant to IL-23 minicircle-induced spondyloarthritis, which limits the utility of this model for mechanistic studies. IL-17A secretion by DN αβ T cell but not γδ T cells correlated with strain-dependent disease susceptibility.


Disclosure: I. Hossain, None; M. Matmusaev, None; J. Ermann, Novartis Pharmaceutical Corporation, 5,UCB, 5,Takeda, 5,SPARTAN/GRAPPA, 9.

To cite this abstract in AMA style:

Hossain I, Matmusaev M, Ermann J. Strain-Dependent IL-17A Secretion By CD4-CD8- DN αβ T Cells Correlates with Disease Susceptibility in Murine Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/strain-dependent-il-17a-secretion-by-cd4-cd8-dn-%ce%b1%ce%b2-t-cells-correlates-with-disease-susceptibility-in-murine-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/strain-dependent-il-17a-secretion-by-cd4-cd8-dn-%ce%b1%ce%b2-t-cells-correlates-with-disease-susceptibility-in-murine-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology